메뉴 건너뛰기
The Lancet
Volumn 374, Issue 9689, 2009, Pages 521-
Insulin glargine and cancer: another side to the story?
Author keywords

[No Author keywords available]
Indexed keywords

HUMAN INSULIN; INSULIN GLARGINE;
EID: 68349150576     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61477-X     Document Type: Letter
Times cited : (28)
References (7)
  • 1
    • 68349148204 scopus 로고    scopus 로고
    • Insulin glargine and malignancy: an unwarranted alarm
    • Pocock S.J., and Smeeth L. Insulin glargine and malignancy: an unwarranted alarm. Lancet 374 (2009) 511-513
    • (2009) Lancet , vol.374 , pp. 511-513
    • Pocock, S.J.1    Smeeth, L.2
  • 2
    • 68449104156 scopus 로고    scopus 로고
    • Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
    • 10.1007/s00125-009-1418-4 published online June 30.
    • Hemkens L.G., Grouven U., Bender R., et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia (2009) 10.1007/s00125-009-1418-4 published online June 30.
    • (2009) Diabetologia
    • Hemkens, L.G.1    Grouven, U.2    Bender, R.3
  • 3
    • 68449104625 scopus 로고    scopus 로고
    • Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
    • 10.1007/s00125-009-1444-2 published online July 9.
    • Jonasson J.M., Ljung R., Talbäck M., Haglund B., Gudbjörnsdòttir S., and Steineck G. Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia (2009) 10.1007/s00125-009-1444-2 published online July 9.
    • (2009) Diabetologia
    • Jonasson, J.M.1    Ljung, R.2    Talbäck, M.3    Haglund, B.4    Gudbjörnsdòttir, S.5    Steineck, G.6
  • 4
    • 68449094354 scopus 로고    scopus 로고
    • Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
    • Scottish Diabetes Research Network 10.1007/s00125-009-1453-1 published online July 15.
    • Scottish Diabetes Research Network. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia (2009) 10.1007/s00125-009-1453-1 published online July 15.
    • (2009) Diabetologia
  • 5
    • 68449094325 scopus 로고    scopus 로고
    • The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    • 10.1007/s00125-009-1440-6 published online July 2.
    • Currie C.J., Poole C.D., and Gale E. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia (2009) 10.1007/s00125-009-1440-6 published online July 2.
    • (2009) Diabetologia
    • Currie, C.J.1    Poole, C.D.2    Gale, E.3
  • 6
    • 68449088664 scopus 로고    scopus 로고
    • Does diabetes therapy influence the risk of cancer?
    • 10.1007/s00125-009-1441-5 published online July 14.
    • Smith U., and Gale E. Does diabetes therapy influence the risk of cancer?. Diabetologia (2009) 10.1007/s00125-009-1441-5 published online July 14.
    • (2009) Diabetologia
    • Smith, U.1    Gale, E.2
  • 7
    • 85102090308 scopus 로고    scopus 로고
    • (accessed July 21, 2009).
    • th (2009). http://en.sanofi-aventis.com/binaries/20090716_Expert_Statement_EN_tcm28-25680.pdf (accessed July 21, 2009).
    • (2009) th

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.